Overview

Study the Safety and Effectiveness of Tadalafil in Men With Diabetes Who Have Problems Getting and Keeping an Erection

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
Study to evaluate the safety and effectiveness of 2.5 mg and 5 mg tadalafil when taken by men with diabetes mellitus who have problems getting and maintaining an erection.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
ICOS Corporation
Treatments:
Tadalafil